Bio-Rad Laboratories Inc
Company Profile
Business description
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
Contact
1000 Alfred Nobel Drive
HerculesCA94547
USAT: +1 510 724-7000
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2025
Employees
7,700
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,787.30 | 15.30 | 0.17% |
CAC 40 | 7,662.59 | 3.32 | -0.04% |
DAX 40 | 23,673.29 | 236.32 | -0.99% |
Dow JONES (US) | 44,494.94 | 400.17 | 0.91% |
FTSE 100 | 8,785.33 | 24.37 | 0.28% |
HKSE | 24,144.10 | 71.82 | 0.30% |
NASDAQ | 20,202.89 | 166.84 | -0.82% |
Nikkei 225 | 39,582.99 | 403.34 | -1.01% |
NZX 50 Index | 12,789.83 | 55.30 | 0.43% |
S&P 500 | 6,198.01 | 6.94 | -0.11% |
S&P/ASX 200 | 8,553.70 | 12.60 | 0.15% |
SSE Composite Index | 3,453.01 | 4.73 | -0.14% |